To The Moon

🌟🌟🌟 $Apple(AAPL)$ is actively shedding its boring defensive outer shell to emerge as a highly lethal weaponised undervalued AI giant.  With the stock breaking out to test new highs around USD 316.83 per share, Apple is about to get a new CEO John Ternus on 1 September 2026 while Tim Cook will be Executive Chairman. Ternus is a product guy who engineered the transition to custom Apple Silicon chips.  His goal is to weaponise Apple's hardware edge & scale on device AI. A September launch for a new premium foldable iPhone Ultra is in the pipeline. Apple is keeping data center costs off their own books by letting Google's Gemini & OpenAI's ChatGPT directly power Siri's massive upgraded ecosystem under the upcoming iOS 27 deployment.

If I had to choose between Target and Estée Lauder after earnings, I’d lean toward $Estee Lauder(EL)$ . The 16% jump is significant, but the results suggest its turnaround may finally be gaining traction. Improving China demand and strong fragrance growth from Tom Ford and Le Labo give me more confidence in its recovery. I also like $Target(TGT)$ setup, with stronger traffic, digital sales growth and a raised full-year outlook. However, part of the EPS strength came from tariff refunds, so I’d like to see more evidence that earnings can continue improving without one-off benefits. For me, EL has more upside potential, while

I would choose $Alphabet(GOOG)$ . Google Cloud’s strong growth, expanding margins and huge backlog show that its massive AI spending is starting to translate into real revenue. I also like the TPU story because it gives Alphabet another potential AI infrastructure advantage beyond relying entirely on Nvidia. For the downgrades, I can understand the argument on PLTR and CRWD. I still think both are excellent businesses, but when valuations become extremely demanding, even strong execution may not be enough to drive further upside. I’d rather wait for a meaningful pullback than chase them after such strong runs. Overall, my strategy is buy quality growth at a reasonable valuation, not quality at any price. GOOG looks more attractive to me today, wh

I think the market is moving early rather than simply getting it wrong. The $NVIDIA(NVDA)$ story has shifted from “how strong is AI demand?” to “where is the money funding that demand?” That uncertainty naturally hits leveraged optical names like $COHERENT(COHR)$ and $Lumentum(LITE)$ first. I don't think AI demand is broken yet. I’m watching actual orders, cash flow and funding much more closely, especially for companies like $

I would not chase Moderna at $174.38. I would rank the three choices: 1. Merck: best risk/reward 2. Wait for full data: best disciplined approach 3. Moderna: highest upside, but highest valuation risk The Phase 3 result is genuinely important. INTerpath-001 hit both recurrence-free survival and distant-metastasis-free survival, validating the personalised neoantigen approach in a pivotal trial.  But Moderna has already repriced the success very aggressively. The market is now capitalising not merely the melanoma indication, but the possibility that this becomes a platform across multiple solid tumours. That is where I would be cautious. Full hazard ratios, subgroup consistency, overall survival, durability, manufacturing economics and regulatory details are still needed. Reuters speci

I would wait for Warsh’s Jackson Hole tone before rotating aggressively back into tech. The Treasury intervention is meaningful, but I would not interpret it as a durable reversal in long-term yields. The 30-year yield had reached about 5.34%, its highest since 2007, before Treasury announced it would at least double long-duration buybacks to $4bn per operation.  The bigger issue is the Fed. July's minutes were more hawkish than the headline "hold" suggests: three officials wanted a 25bp hike, several saw inflation as broad-based, and there was no meaningful discussion supporting a cut. Markets are even assigning better-than-even odds to a hike by October or December.  So my positioning would be: Tech: cautiously add, not chase. Lower yields provide exactly the relief that high-d

I would buy SK Hynix on weakness, rather than step away from memory. My preference is SK Hynix > Samsung > avoiding the sector. The key distinction is that SK Hynix's payout is not simply management saying, "we have run out of attractive investments". It is explicitly buying and cancelling 40 trillion won of shares, while raising its target to return more than 50% of 2025-27 cumulative FCF. That is a direct reduction in share count and a strong signal management believes the stock is undervalued.  Samsung is potentially even more interesting as a value + dividend play, but the >100 trillion won figure remains a media report awaiting board approval. The reported plan would allocate 50% of FCF to shareholders, with dividends expected to dominate.  I don't see the payouts a

I have been watching the Treasury market closely these past few weeks, and the latest move feels like a quiet admission that things are getting uncomfortable at the long end of the curve. Treasury just doubled the size of its liquidity-support buybacks in the 10-to-20-year and 20-to-30-year sectors to at least $4 billion per operation. This comes right after the 30-year yield pushed toward levels we haven’t seen in nearly two decades and the 10-year settled in the mid-4.6% range. On paper, these buybacks are still framed as liquidity tools helping dealers offload older, less-traded bonds. In practice, the timing and the sudden upsizing tell a different story. When yields keep rising even on the day of a scheduled buyback, and Treasury responds by expanding the program off-calendar, it look

$MSTR 20260918 90.0 CALL$ what will be the value after mkt open later of the day... cheers

Hello everyone! Today i want to share some technical analysis with you! 1 $Health Care Select Sector SPDR Fund(XLV)$ soaring to new all-time highs after a historic day on the mission to cure cancer 2 Long-term Treasury prices are currently trading at 22-year lows... Yes, 22-year lows. Persistent inflation, ballooning government debt, and uncertainty around the Fed have investors demanding much higher yields to hold long-term debt. $iShares 20+ Year Treasury Bond ETF(TLT)$ 3 Pressure building at a level $Meta Platforms, Inc.(META)$ simply refuses to give up 🌡️ 4 Another mean Stage 2 breakout after a strong Q2 earnings